Convatec Group Stock News

BOSTON--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announced it has been recognized by Vizient®, the largest provider-driven healthcare performance improvement company in the United States, with two distinguished supplier awards, including 2026 Non-Acute Supplier of the Year and 2026 Medical and S...

JP Morgan has reiterated its 'overweight' rating on ConvaTec Group PLC (LSE:CTEC), saying the medical products group is well positioned to meet its 2026 earnings guidance and that its 2027 outlook is increasingly secure ahead of a trading update next month. A research note ahead of ConvaTec's 10-month trading update on 18 November said the bank had made changes to its divisional growth mix for ...

LONDON--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in pre...

BOSTON & LONDON--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announces the launch of Cure Aqua™ in the United States and Canada.The latest addition to Convatec's Cure™ catheter portfolio, Cure Aqua™ is a ready-to-use hydrophilic intermittent catheter designed to support a comfortable catheterizatio...

British medical products maker Convatec on Tuesday forecast its second-half operating margin to be materially higher ​than the first half, and pointed to accelerating ‌demand for its infusion care products.